Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
๋์ ์ฑ์ฅ
ํ์ฌ์ ๋งค์ถ์ ์ง๋ 3๋
๊ฐ ๊พธ์คํ ์ฑ์ฅํด์์ผ๋ฉฐ, ์ฐํ๊ท 22.28%์ ์ฆ๊ฐ์จ์ ๊ธฐ๋กํ์ต๋๋ค.
์ฑ์ฅ ์ค
ํ์ฌ๋ ์ฑ์ฅ ๋จ๊ณ์ ์์ผ๋ฉฐ, ์ต์ ์ฐ๊ฐ ์์ต์ ๋ฏธํ 65.27M์ ๋ฌํฉ๋๋ค.
๊ณผ๋ ํ๊ฐ๋
ํ์ฌ์ ์ต์ PE์ -0.33๋ก, ์ต๊ทผ 3๋
๊ธฐ์ค ๋์ ๋ฐฑ๋ถ์ ๋ฒ์์ ์ํฉ๋๋ค.
๊ธฐ๊ด ๋งค๋
์ต์ ๊ธฐ๊ด ๋ณด์ ์ฃผ์ ์๋ 1.44M์ฃผ์ด๋ฉฐ, ์ ๋ถ๊ธฐ ๋๋น 55.80% ๊ฐ์ํ์ต๋๋ค.
์ ์์ค ์ฌ์ด๋จผ์ค๊ฐ ๋ณด์
์คํ ํฌ์์ ์ ์์ค ์ฌ์ด๋จผ์ค์ด(๊ฐ) ์ด ์ฃผ์ 0.00์ฃผ๋ฅผ ๋ณด์ ํ๊ณ ์์ต๋๋ค.
์์ฅ ํ๋ ์ฆ๊ฐ
ํ์ฌ๋ ํฌ์์๋ค์ ๊ด์ฌ์ด ๋์์ ธ, ์ต๊ทผ 20์ผ๊ฐ ํ์ ์จ์ด 6.18์
๋๋ค.